HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Swarnendu Kaviraj Selected Research

Swarnendu Kaviraj Research Topics

Disease

4Malaria
01/2022 - 11/2015
3Infections
11/2023 - 01/2018
2Visceral Leishmaniasis (Kala Azar)
11/2023 - 01/2021
1COVID-19
04/2024
1Neglected Diseases
11/2023
1Leishmaniasis
11/2023
1Cutaneous Leishmaniasis
11/2023
1Ovarian Neoplasms (Ovarian Cancer)
11/2022
1Neoplasms (Cancer)
11/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Bites and Stings (Sting)
01/2021
1Hepatitis B
01/2018

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
04/2024 - 11/2015
1Messenger RNA (mRNA)IBA
04/2024
1AntigensIBA
11/2023
1leishmaninIBA
11/2023
1Recombinant ProteinsIBA
11/2022
1liposomal doxorubicin (Doxil)FDA Link
11/2022
1AntibodiesIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Carrier Proteins (Binding Protein)IBA
10/2021
1Leishmaniasis VaccinesIBA
01/2021
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
11- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
01/2018

Therapy/Procedure

1Therapeutics
11/2022
1Drug Therapy (Chemotherapy)
11/2022
1Intradermal Injections
01/2021